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THE CASE FOR THE USE OF ANIMALS IN MEuiCJNJ!; 1
Gary F. Merrill2

Introduction
As early as 1500-500 B.C., there are indications of Vedic (Hindu) records
of animals being observed by man for medical and scientific purposes. In
300 B.C., in Alexandria, Egypt, Erasistratis placed live birds in closed containers
and withheld food to observe the consequences of losing body humors.
This is believed to be the first recorded attempt to use live animals for
research. The philosopher Aristotle (384-322 B.C.), also a biologist and the
son of a physician, founded the sciences of physiology, zoology, and comparative anatomy as a result of his observations of animals. Galen (130-200 AD.),
a physician, anatomist, physiologist, and philosopher, was the founder of
experimental physiology. His animal studies were designed to be applicable
to humans; their accuracy and completeness greatly improved the understanding of the human body. After the fall of the Roman Empire and during the
Dark Ages, the decline that occurred in the arts and sciences was evident
in both human and veterinary medicine.The unity that had existed between
the two branches of medicine did not reappear until the Renaissance. Thus,
the seventeenth and eighteenth centuries saw significant medical advances,
many the result of animal studies (Davison 1977).
The use of animals in medical research and teaching, and the public
concern this has generated is not a new issue (Visscher 1969). Ever since
scientists began using animals to investigate the function of the body in
health and disease, there have been those who opposed their work (Fishman
and Richards 1982). Whether this controversy is cyclic is not known, but
most concerned biomedical investigators agree that the opposition is here
to stay. The author shares this opinion, and thus maintains that it is in the
best interest of all parties to be properly educated on the issues. Only
through the process of education can we accurately evaluate the pros and cons.
The issues to be addressed in this paper entitled "The Case for the Use
of Animals in Medicine" include: 1) a selected sample of animals used in
biomedical research and teaching and, 2) a selected sample of diseases which
have plagued (do plague) man and other animals, and in which animal
research has played a major role in minimizing the suffering and early loss
of life. The subject is broad and other, more complete, reviews are available
(Sechzer 1983).
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Animals Used in Medical Research
Beginning in June, 1984, the American Physiological Society, one of the
many professional biomedical societies dedicated to educating the public
and supporting the responsible use of animals in medical research, published
a series of articles entitled, "Health Benefits of Animal Research" (Gay 1984).
The series, which identifies several animal species currently being used as
research subjects in medicine, and the benefits to human health derived
from such research, concluded in April, 1985 (King and Yarbrough 1985).
These anicles are being reproduced as separate chapters in a book entitled,
Health Benefits ofAnimal Research, by the National Association of Biomedical
Research, Washington, DC. Much of the information presented in the following
section of this paper was taken by permission from this material.
Dog -The dog has been a companion to man since the dawn of history.
As a result of this relationship, both the dog and man have experienced
advantages and disadvantages. It is quite logical why this animal was chosen
by early biomedical investigators as the species of choice for their scientific
experiments. In laboratory surroundings, the dog is smaller and easier to
maintain than large agricultural animals. Rats and mice at the time were not
thought of in terms of human health and welfare, but rather were disdained
as transmitters of disease. Stray dogs were generally abundant then, as now,
in urban areas.
The dog's gregarious behavior and highly-developed social nature enhance
his manageability in the laboratory. This good nature was recognized and
appreciated by earlier medical and behavioral scientists, including Pavlov
(1927). Consequently, behavioral genetics has been the subject of considerable research with the dog (Scott and Fuller 1965). Amongst the many clinical
diseases for which the dog has been an important research subject are: 1)
hereditary spinal muscular atrophy (similar to human motoneuron disease
[Cork et a!. 1979]); 2) arterial diseases and diseases of the heart, including
endocarditis (Keys et a!. 1972); 3) hepatitis (Morris and Gocke 1971) and
ethanol-induced liver cirrhosis (Chey eta!. 1971); 4) neoplastic disease (Dewhirst et a!. 1983 ), including the use of chemotherapy to treat infectious
cancer; 5) cholera (Sack and Carpenter 1969); and 6) nutritional disease,
including a niacin deficiency syndrome similar to human beriberi (Yang and
Mickelson 1974). Perhaps the most well known of all such diseases for which
the dog has been used experimentally is diabetes mellitus (see "Diabetes"
below).
Rat.- The rat is used experimentally in the fields of immunology, reproduction, cancer, behavior, and aging, amongst others. It is also of universal
economic importance since it destroys one-fifth of the world's crops annually
and transmits a variety of diseases to humans (Canby and Stanfield 1977).
The consequences to man of the rat's destructive activities and its major
contributions to human health through biomedical research make the rat
one of the most important species with which man must continue to interact.
The strain of rats that has been used most for experimental biomedical
research is the Norway rat (Rattus norvegicus), and its early history has been
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described by Robinson (1965). In the middle of the nineteenth century, the
rat was used for studies in nutrition, physiology, and anatomy The research
rats used in the United States are thought to have originated in Europe. The
first inbred lines of rats were developed independently by several groups
of investigators at the beginning of the twentieth century The first studies
were in basic genetics and cancer research.
The rat is a major animal for the biomedical investigation of aging. Inbred
and randomly-selected strains show major spontaneously-developing, agerelated diseases of the heart and kidneys, as well as the nervous, endocrine,
skeletal, and immune systems (Baker et al. 1979). Rats are susceptible to the
development of: 1) spontaneous, 2) virally-induced, and 3) chemicallyinduced tumors in all organ systems (Baker et al. 1979). The rat provides
models for both diabetes mellitus and diabetes insipidus. The rat is the best
animal model currently available for the study of spontaneous, insulin-dependent (juvenile onset) diabetes in humans (Baker et a!. 1979).
Rabbit.- Because the general physiology of cells, sera, tissues, and organs
of rabbits exhibit a similarity to that of humans, rabbits have been and will
continue to be excellent models for many human diseases. The rabbit is
large enough to provide adequate quantities of tissue for experimental work
without pooling of samples, but is small enough to be more economical
than pigs, monkeys, or dogs. Blood samples can be taken without serious
harm to the animal from birth to adulthood in sufficient quantity for performance of routine biochemical tests. Rabbits are an excellent mammalian
model system for the investigation of placental transfer of drugs, steroids,
and other metabolites due to the fact that the rabbit and human have the
same type of placenta (hemochorial), which allows the closest contact
between maternai and fetai circuialions (Fox et ai. 1982; Kozma el ai. 1974).
Degenerative diseases occur with increasing age in man and all other
species. To study the aging process, the National Institute of Aging suggested
the rabbit as a species of potential use ( CAMRA 1981). There are a number
of changes that have been observed in rabbits with increasing age, including:
1) changes in blood composition, 2) cardiovascular changes, 3) endocrine
levels, 4) nerve responses to stimuli, and' 5) visual parameters.
The author has recently noted the similarity between the response of
coronary arteries to the vasoconstrictor effects of histamine in the rabbit
(Tozzi and Merrill 1985) and those reported in humans (Ginsberg et al. 1981;
Toda 1983 ). Interestingly, in the rabbit, histamine administration can cause
ischemic (lack of coronary blood flow) heart disease (Tozzi and Merrill
1985). This disease causes anginal pain in humans and is associated with
high mortality in industrialized nations. Thus, the rabbit might prove to be
an acceptable animal model in which to study coronary heart disease.
Subhuman Primates.- Primates share more biological and behavioral
characteristics with humans than do any other animal species. These interesting similarities begin with the basic chemical component of life, deoxyribonucleic acid (DNA); ninety- eight percent of the molecular composition of
human DNA can be found in subhuman primates.
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While anthropologists study subhuman primates for clues to human origins
and nature, behavioral scientists examine social organization and interactions
in these animals seeking to understand principles governing sexual behavior,
aggression, and other social behaviors. In neurobiology, immunology, pathology, reproductive biology, teratology, neonatology, and cardiology, subhuman
primates are indispensible biomedical research models for both understanding basic physiological mechanisms and the development of new approaches
to the diagnosis and treatment of disease.
Until the 1960s, cardiovascular research was conducted primarily in rabbits,
dogs, chickens, rats, and swine. Subhuman primates became major subjects
of heart research when it was discovered that atherosclerotic vascular plaques
were similar developmentally, microscopically, and biochemically in humans
and monkeys (Taylor et al. 1962, 1963a, 1963b). Subhuman primates now
are used in cardiovascular research with the following objectives: 1) to
identify the mechanisms of atherosclerotic destruction at the organ, cellular,
and molecular levels (Ross 1983); 2) to understand the role of diet, blood
pressure changes, and other factors in the advancement and stabilization of
the disease (Matt et al. 1983); and 3) to define the relative influence of risk
factors (tobacco, alcohol, hypertension, obesity, etc.) on disease progression,
regression, and prevention (Wissler 1980).
The subhuman primate is also being used in non-cardiovascular disease
research. Hepatitis B is a viral disease that annually afflicts 200,000 people
in the United States alone. There are approximately 200 million carriers of
hepatitis B worldwide. At least three million infants born in Southeast Asia
alone will become carriers and develop severe liver damage, including liver
cancer (King and Yarbrough 1985). In 1981, the United States Food and Drug
Administration approved the world's first hepatitis B vaccine (Maugh 1981).
This major advance depended on research with chimpanzees and other
subhuman primates, since hepatitis B cannot be transmitted to other laboratory animals.
Other areas of biomedical research in which subhuman primates are being
studied include AIDS and vision research. (The chimpanzee is thus far the
only laboratory animal that has proven susceptible to the AIDS infectious
agents (McClure et al. 1984; Science News 1984). One of the most recent
contributions of primate research to human clinical treatment has been the
studies of Wiesel and Hubel (Wiesel 1982). These studies, for which the
authors received the Nobel Prize, involved the development and functioning
of the visual system in monkeys. Their results underlie the emphasis on
early diagnosis and treatment of human infants with visual disorders.
Cats.-Cats made the cover of Time magazine, December 7, 1981 (Reed
1981). They made it for their capacity as people pleasers, their role as the
country's most adaptable companion animal, and their potential as a new
source of revenue for cartoonists and merchants who have recognized the
eat's national popularity. It is estimated that there are 34 million cats inhabiting
24% of the households in America, and another 15 million who are homeless.
In the past 30 years, the health of the house-dwelling cat has improved to
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such a degree that a life expectancy increase of six to eight years allows
many felines to reach the age range of 16-20 years. Improvement in the
feline's health has been brought about, in great part, by better nutrition,
new and improved diagnostic procedures and surgical techniques, and treatment and drug therapies for such conditions as feline urolithiasis, skin
disorders, fractures, conjunctivitis, anemia, tumors, and pneumonia, and vaccines for the prevention of many life-threatening diseases such as feline
enteritis, rhinotracheitis, pneumonitis, and most recently for feline leukemia
(Lewis et al. 1981). This improved quaiity of iife for felines couid not have
been brought about without the aid of biomedical research-research which
often relied on the cat as the subject.
Not dealt with in the Time article was the eat's contribution to medical
research, perhaps because it is a very unpopular subject with a small segment
of the public (Cornelius 1969).
In 1894, Murey, a French physiologist, used the motion-picture camera to
illustrate how the eat's body changed position when it was dropped from a
height, landing eventually on its feet (McDonald 1960). This observation led
physiologists in the early 1900s to examine the physiology of the falling
reflex and to come to the conclusion that the brain, and either the eyes or
the balancing mechanism (vestibular organs) in the ears, were essential to
the eat's landing on its feet. It was not determined, until 1960, that of the
two systems, the eyes were more important (Beadle 1977; McDonald 1960).
It is not uncommon for cats that are well cared for to reach the age range
of 16-20 years. Thus, this species is suitable for investigating the aging process.
It is of interest that many of the procedures used to study aging do not
require surgical intervention, nor do they adversely affect the health and
wellbeing of the animal. Studies of the aging process in cats has yielded
information of relevance to both man and pets, an important factor in view
of the increased interest in the role of companion animals, especially for
the older population. Although animals (cats, dogs, birds, fish, reptiles) are
being prescribed for their therapeutic value with the mentally retarded,
physically handicapped, and prisoners, one of their most valuable contributions is with the aged population; cats are the animal most often used in
these settings.
Behavioral scientists use the cat for studies of behavioral development,
comparative evaluation, and behavioral assessment. Examples of human conditions studied in the cat include neuroses, amphetamine psychosis, learning
and memory, socialization, and habit formation. Of the many diseases cats
and humans share, probably one of the best known is leukemia. The causative
agent of leukemia in the cat is a ribonucleic acid (RNA) virus belonging to
the family Retroviridae, a retrovirus. Of great current medical interest are
the reports of retroviruses associated with AIDS in humans (Sarngadharan
et al. 1984) and SAIDS (Simian Acquired Immune Deficiency) in animals
(Marx et al. 1984).
Mice.- Throughout history, mankind has suffered the ravages of disease.
Plagues have decimated large segments of the population. Hundreds of
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millions of people died from the "black plagues" caused by Yersinia pestis,
a bacterium transmitted from rodents to humans via fleas, or by infectious
droplets from pneumonic victims. In the early 1900s during the influenza
virus pandemic, bacterial meningitis and pneumonia associated with
Haemophilus influenza caused countless deaths. As late as 1950, whooping
cough caused by Bordetella pertussis killed over 1,000 American children.
The threat of bacterial disease is not a thing of the past as evidenced by the
recent experience in the United States with Legionnaires' Disease caused by
a newly recognized bacterium Legionella pneumophila.
Parasitic diseases are a major cause of human death and suffering. Schistosomiasis, a blood fluke affecting millions of people, is fortunately of limited
public health importance in the United States.
The mouse has played a fundamental role as an experimental animal in
many of the infectious diseases just discussed. Mice were, and, in many cases
still are an essential part of diagnostic medical microbiology. They are important
in viral isolation studies of diseases caused by arthropod-borne vectors and in
rabies virus diagnosis. Mice are still a significant investigative model for understanding basic host mechanisms of disease, and for studying susceptibility and
resistance to infectious agents Qonas 1984). Abasic understanding of host-parasite
relationships is critical if we are to achieve better diagnostic, preventive
medical approaches, and therapeutic applications to these problems.
In addition, there is a long list of diseases of humans that are usually
thought to be non-infectious but cause immense suffering and in many cases
contribute to mortality. Arthritis, diabetes mellitus, central nervous system
disorders, immune deficiency diseases, metabolic disorders, hematologic
dyscrasias, and cancer are diseases that are all too familiar. The use of mice
has provided us with a valuable method to elucidate fundamental biological
phenomena associated with these diseases. Through creative basic and
applied research studies, we have developed effective therapeutic measures
for infectious and noninfectious diseases.
Abnormalities of development are frequently associated with genetic dysfunction. Down's syndrome is a tragic example of a chromosome disorder
resulting in a child with a "mongoloid" appearance, mental retardation,
cardiac abnormalities, and an increased likelihood of developing leukemia.
Through plant and animal investigations, we have gained an understanding
of genetic disease that has enabled us to diagnose and, in some cases, treat
genetic disorders. Genetic counseling of prospective parents is now commonplace. The use of mice in studying basic genetics at the classical and
molecular levels has resulted in development of organ transplantation as
well as effective methods to modify the course of immunologic disease. With
advances in molecular biology it is now possible to think in terms of modifying
genetic errors of metabolism by gene manipulation.
The history of microbiology is intimately interwoven with experimental
studies using mice. Pasteur used mice in studying both rabies and anthrax.
Mice were at the forefront of experiments dealing with the nature of infectious
disease and immunization. The mouse has been and will continue to be an
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excellent research animal to study the pathogenesis of bacterial diseases.
For example, a model for human antimicrobialassociated diarrhea (MD)
was developed using Clostridium difficile as a causative organism. This work
used the mouse as the experimental animal (Onderkonk et al. 1980).
Developmental analysis of an animal model of a human disease makes it
possible to determine what happens metabolically before the actual disease
symptoms appear. Not only does this understanding of a disease's progress
help design therapy but also allows early detection and treatment. Because
so many genes have been mapped in the mouse (Pearson et ai. 1982), it is
usually possible to identify the presence of a disease-causing gene early by
"tagging" it with a closely linked marker gene. One example of this is the
diabetes gene (Coleman 1978), which is closely linked to a coat color gene
in the mouse called misty (m) (Wooley 1943, 1945). By making appropriate
matings, it was possible to link the diabetes gene (db) with the m gene.
Thus it is possible to follow the development of diabetes from shortly after
birth by simply analyzing those mice with the misty coat color. Analysis of
the db gene in mice has led to a better understanding of the complex nature
of hormonal abnormalities on cellular metabolism.
Mice are also being used to study the structure of immunoglobulins,
diseases of the blood-forming elements such as aplastic anemia or leukemia,
and in the development of blood assay systems, e.g., there are at least 17
different mutations in the mouse that cause anemias (Russell 1979).
Medical Advances Made Tht·ough Animal Research
Diabetes.-The term diabetes mellitus comprises a heterogeneous group
of disorders characterized by high blood glucose levels. Approximately 5.8
million people in the United States have been diagnosed by a physician as
being diabetic, and an additional four to five million people have diabetes
but have not yet been diagnosed (approximately 500,000 new cases are
diagnosed annually). There are four main types of diabetes. Insulin-dependent
diabetes mellitus (IDDM) constitutes about 510% of all cases of diabetes,
and most of the remainder is noninsulin-dependent diabetes mellitus
(NIDDM). About 2% of diabetes is the type that is secondary to or associated
with other conditions. Gestational diabetes, a transient condition occuring
in about 2-5% of pregnancies, is one such malady.
The annual incidence of IDDM is about 12-14 new cases per 100,000
children ages 0-16 years, and by age 20, about 0.3% of persons have developed
IDDM. About one-half of the persons with IDDM are currently older than
age 20 years. The annual incidence of NIDDM is about 320 per 100,000
persons ages 20 years or older. About 2.35% of the population has been
diagnosed as having NIDDM, and at ages 65 years and older, virtually 8.6%
have NIDDM.
Diagnosis of diabetes is made either by the presence of the classical
symptoms of diabetes accompanied by elevated blood glucose levels, by
elevated fasting glucose levels, or by an abnormal oral glucose tolerance test.
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In 1982, 34,583 deaths were attributed to diabetes as the underlying cause
of death, resulting in diabetes being ranked as the seventh leading underlying
cause of death. In approximately 95,000 additional deaths, diabetes was listed
as a contributing cause of death. The majority of death certificates (about
75%) listing diabetes also list a cardiovascular condition. Ischemic heart
diseases are involved in about 60% of diabetes deaths, and cerebrovascular
diseases in about 25%.
Diabetes is not a benign disease. It causes almost 50% of amputations of
the foot and leg among adults. It causes about 20% of all cases of kidney
failure and 15% of all blindness. Diabetes in the mother causes about 3%
of all stillbirths and neonatal and perinatal deaths. The United States ranks
among the highest five nations in the world in mortality due to diabetes.
It is of interest that the first major preclinical breakthrough in diabetesrelated research was achieved in dogs (Best 1974). It had been shown by a
variety of investigators that complete removal of the pancreas always resulted
in fatal diabetes. Dogs were the experimental animal. Therefore, it was
inevitable that Fred Banting and Charles Best would choose the dog as the
experimental animal for their studies which lead to the ultimate discovery
in insulin (Best 1974). Both Banting, an expert surgeon, and Best, a medical
school student studying experimental physiology, had personal interest in
diabetes. Dr. Banting had watched a child in Alliston, Ontario, lose weight
and eventually develop diabetic coma and die. An aunt of Charles Best
developed diabetes in 1912. The only !mown therapy at the time was the
under-nutrition regimen (Allen et al. 1982). Best's aunt followed the diet
faithfully, but died of diabetic coma in 1918 (Best 1984).
When these investigators were provided with research facilities in the
Department of Physiology, University of Toronto, in 1921 to study the disease,
they were told that only ten dogs would be provided for their proposed
studies. The cost per animal in those days was approximately one dollar.
When the ten dogs had been used, and suitable results were still lacking,
Banting and Best purchased additional dogs with their own funds. In those
days, they had no stipends or grants to support their research. In final studies
(August and September, 1921), they performed scores of experiments providing convincing evidence that the secretory extracts of beef pancreas (they
and others had hypothesized that presence of an anti-diabetic factor) could
reverse the symptoms seen in diabetic (pancreatectomized) dogs.
Because of personal interest in the outcome of their experiments, they
looked after the dogs themselves; fed them and cleaned their cages. They
trained the dogs to put out their paws for withdrawal of blood samples and
they made the dogs as comfortable as possible under the circumstances. In
the words of Charles Best, "I do not think that in these or subsequent
experiments we ever inflicted pain and discomfort on dogs which we would
not have been willing to accept ourselves" (Best 1974). The animals that
were pancreatectomized before insulin was available and which lived for
ten days to two weeks, were necessary as controls for the animals that
received insulin.
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Banting and Best presented the results of their research before the
Physiological Society in Toronto in November, 1921, and before the American
Physiological Society in December, 1921. On January 10, 1922, they gave each
other injections of their purified insulin (Best 1974). There were no untoward
effects except a mild soreness of their arms. On the following day, the
material was taken to Toronto General Hospital where a 14-yearold boy,
Leonard Thompson, became the first diabetic to receive insulin. The first
patient to receive insulin in the United States was James Havens of Rochester,
New York. I-Ie became a celebrated artist and lived to help raise a fine family
The travels of Banting and Best in some 70 different countries brought
them in contact with thousands of diabetics. Statisticians have told them that
figures based on worldwide consumption of insulin indicate that some 130
million diabetics have had their lives prolonged by insulin (Best 1974). Today,
of course, the number is even greater.
Fred Banting and Charles Best had two great hopes in 1921 and 1922. The
first hope was that the dramatic recovery of diabetic animals could be
consistently produced by insulin in human patients. The second was that
insulin would become an important agent in metabolic research. Both hopes
have been realized. As evidenced by the fact that volumes have been written
on these two subjects, it is safe to say that perhaps no other physiological
agent has been so instrumental in revealing so much about the intermediary
metabolism of carbohydrates, fats, and proteins, as has insulin.
Childhood Communicable Diseases and Vaccines. -A report of "teething
paralysis" by Colmer (1843) is thought to be the first description of an
outbreak of paralytic poliomyelitis in the United States. For many years,
poliomyelitis was primarily manifested as an endemic disease, occurring
sporadically among infants and young children, but in the early years of this
century, epidemics began to appear, and so-called "infantile paralysis" was
soon reported in older children and adults (Paul 1971).
During the 1940s, there was a marked increase in the incidence of poliomyelitis
in the United States. For example, between 1920 and 1940, there was an
annual incidence of about five cases per 100,000 population. By 1945, the
incidence had risen to approximately 15-20 cases per 100,000, and by the
early 1950s, it had escalated to an estimated 40-45 cases per 100,000 population
(Salk 1980). Similar increases were observed in other developed countries
at the time, while developing countries noted an increased incidence and
shift from an endemic to epidemic pattern (Paul 1958).
The conquest of polio began in 1909, when Landsteiner and Popper (1909)
demonstrated that poliomyelitis could be transmitted from humans to apes
and monkeys. Subhuman primates became a key animal model for studies
on the pathogenesis of polio and for vaccine development when it was
recognized that among animal species, only monkeys and chimpanzees could
contract human poliomyelitis.
After a decade of intense, focused research employing mice, cats, chick
embryos, and subhuman primates Qonas Salk, personal communication), a
killed poliovirus vaccine (KPV, sometimes referred to as inactivated poliovirus
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vaccine) was introduced into general use in the United States in 1955. This
followed a large-scale, controlled field trial in 1954 (Francis et al. 1955), in
which the author, and numerous other American children became the first
recipients of the protective effects of the polio vaccine. Between 1955 and
1962,there was a sharp decline in the incidence of poliomyelitis in the United
States, decreasing to fewer than five cases per 100,000 population; a decrement
of approximately 95%.
The impact of the polio vaccine on human health, developed totally through
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the peak years of the polio epidemic in the United States, there were an
estimated 50,000-60,000 cases reported per year. Many victims died or were
left permanently crippled. In the immediate years following a federally-subsidized campaign to vaccinate all American children, there were fewer than
ten cases per year (Salk 1980).
Similar results, based on research in animals, have had impacts on other
communicable childhood diseases. In 1934, before final development and
routine administration of the pertussis ("whooping cough") vaccine, more
than 265,000 cases were reported in the United States. More than 7,500
victims died. In 1982, there were fewer than 2,000 reported cases with about
four deaths.
In 1980, the World Health Organization announced the worldwide elimination of smallpox. Hence, the development of vaccines against communicable diseases, resulting from animal research, has provided society-wide
health benefits. Today, all 50 states require routine vaccination of children
against smallpox as a condition for entering school.
Interestingly, the protection against such epidemics cannot be extended
to subpopulations who refuse vaccination. Fox et al. (1971) described an
outbreak of smallpox in a well-immunized community in eastern Nigeria
that was confined entirely to members of a small religious sect who refused
vaccination. This group was dispersed throughout the community, but maintained close social ties and relative segregation from the rest of the population.
The 1978 and 1979 outbreaks of poliomyelitis in The Netherlands, Canada,
and the United States are strikingly similar to the above example. Since 1961,
outbreaks of poliomyelitis in The Netherlands have occurred only in certain
Protestant communities with very low vaccine acceptance rates. Between
April 15 and October 12, 1978, a total of 110 cases of poliomyelitis (80
paralytic, 30 non-paralytic) occurred in several different Dutch provinces
amongst members of a Protestant religious denomination that refuses vaccination. The majority of the cases (99) occurred among 65,000 unvaccinated
individuals under 27 years of age (Bijkerk 1979). This outbreak was geographically widespread, but no cases of poliomyelitis occurred among 435,000
unvaccinated individuals under age 27 who were not members of these
religious denominations. Also in 1978, several cases of poliomyelitis were
reported among members of a religious group in Canada. This latter group
is related to the group involved in The Netherlands outbreak (Furesz 1979).
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There had been contact between the Canadian group and visitors from The
Netherlands prior to the outbreak
In 1979, poliomyelitis appeared in the largely unvaccinated Amish population of the United States, which includes approximately 75,000 members
(CDC 1979). The first paralytic case occurred in January in a Pennsylvania
town to which a Canadian family had recently moved from a town in Ontario
near an area affected with poliomyelitis in 1978. There are extensive interactions among members of different Amish communities, including contact
betv1een groups in the United States and Canada. By n1id-spring, it was
apparent that wild poli0 virus type 1 was circulating widely within these
communities. The virus was shown to be similar to that circulating in Canada
and The Netherlands. By June, 1978, when vaccination campaigns appeared
to have controlled the outbreak, a total of 15 paralytic and two non-paralytic
cases had been reported.
Cardiovascular Disease.- The story of the diagnosis, treatment, and prevention of cardiovascular disease is the story of animal research. It begins
in antiquity with the discovery of the structure and function of the heart,
vasculature, blood, and lungs (Fishman and Richards 1982). Of prominence
in this story is the discovery by William Harvey (1578-1657) of the circulation
of the blood, a feat based on years of observation and experimentation in
animals. By an extraordinary chance, the notes of his Lumleiam lecture of
April 17, 1616, found their way into the British Museum, where they were
discovered in 1886, some 270 years later. Excerpts from these notes, written
originally in Latin and English are worth quoting (Franklin 1933):
It is plain from the structure of the heart that the blood is passed continuously
through d1e lungs to the aorta as by two clacks of water bellows to raise water.
It is shown by application of a ligature that the passage of blood is from the
arteries into the veins. Whence it follows that the movement of the blood is
constantly in a circle, and is brought about by the beat of the heart. It is a
question, therefore, whether this is for the sake of nourishment or of heat,
the blood cooled by warming the limbs, being in turn warmed by the heart.

Bear in mind that his predecessors were convinced that the heart was the
source of body heat production and expelled a mixture of blood and air,
but not in a circular fashion (Sarton 1954). Harvey continued such experiments throughout his life although it is not always easy to determine just
what these experiments were and when he did them. An elegant experiment
in the perfusion of the pulmonary circulation is described in a letter written
late in his life to his friend Paul Marguat Siegel of Hamburg (Harvey 1766).
... the pulmonary artery and aorta are ligated, the left ventricle opened, and
a cannula placed in the vena cava, and water forced in. Quid fit? [What happens?]
The right ventricle is vehemently tumefied. Through the opening in the left
ventricle, however, not a drop of water or blood escapes ... .So now (the
solution having been predicted), the syringe is introduced into the pulmonary
artery, with a ligature around it lest water regurgitate into the right ventricle.
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We force the water in the syringe against the lungs and immediately water
with copious amounts of blood leaps out of the cleft in the left ventricle, so
that as much water as is expressed into the lungs, so much flows out of the
hiatus mentioned. You can experiment as often as you like, and know for
certain that this is so.

These and similar experiments designed to prove that blood flows in a
circular fashion, i.e., from right ventricle to lungs, thence through the left
ventricle to the systemic circulation, and back to the right ventricle, are
detailed in Harvey's classic book, Exercitatio anatomica de motu cordis et
sanguinis in animalibus, ( Guilielmi Harvei, Angli, Francofurti, sumptibus
Guilielmi Fitzeri, anno M. DC. XXVIII [Harvey 1928]). This great work in
experimental physiology stands by itself. In the medical sciences, there is
nothing else in the same class. Its seventeen brief chapters, in 72 pages, are
an inexhaustible source of enlightenment and incontrovertible conclusions.
Its achievement was more than a discovery: it was a revolution (Fishman
and Richards 1982).
Animals, like humans, suffer from many inherited cardiovascular defects,
including patent ductus arteriosus, pulmonary stenosis, persistent right aortic
arch, intraseptal defect, and both tricuspid and mitral valve insufficiencies.
All of the preceding maladies are seen in the dog. Vascular disease, common
in the aging dog, is treated clinically in many veterinary practices with drugs
and other methods of therapy developed during the last couple of decades
for use in humans.
Replacement of heart valves and segments of larger arteries are major
cardiovascular advances resulting almost entirely from dog surgery 30 years
ago. Hemophilia in the dog is an inherited hemostatic defect considered
nearly identical to that seen in humans; it is more frequently reported in
dogs than in most other domestic animals (Gay 1984).
One in every two deaths of Americans today can be attributed to cardiovascular and related disease. The incidence of such diseases, which steadily
increased in the post-World War II years, has been on the decline for the
past couple of decades. This is due in large measure to the promotion of
accelerated activity in biomedical research by the federal government, the
biomedical scientific community, and private enterprise. With such promotion
has come advanced technology that allows us to intervene in the advancement
of cardiovascular disease with new surgical and pharmacological insight that
was thought impossible 20 years ago. For example, the early loss of life due
to ischemic heart disease (secondary to organic vessel disease, i.e.,
atherosclerosis) has been greatly reduced with the development of coronary
bypass surgery. It should be of little surprise that before such technology
was applied to human medicine, it was first thoroughly investigated in
experimental animals. Large agricultural species such as sheep, hogs, and
cattle, and smaller domestic species such as dogs, were routinely investigated
to determine the feasibility of such surgical/pharmacological intervention in
man. Few of us are not familiar with persons whose life expectancy has
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been prolonged as the result of coronary bypass surgery. Valve replacement
surgery is another intervention routinely performed in man which was first
tested and perfected, as far as was possible, in experimental animals.
In November, 1983, the author attended the annual meeting of the American
Heart Association held in Anaheim, California. This meeting occurred less
than one year after surgeons at the University of Utah Medical Center replaced
the first human heart with an artificial counterpart. Drs. William C. DeVries
(heart surgeon) and Robert K.Jarvik (heart designer) were both in attendance,
as was the wife of Dr. Barney Clark, the first human recipient of a transpla..11.ted
artificial heart. Dr. DeVries was the keynote speaker. He outlined in considerable detail the years of animal experimentation at the University of Utah
and elsewhere which preceded this first human experiment. Dr. DeVries
described the experience as follows (DeVries et al. 1983):
Advances in bio-engineering and animal experimentation have led to the possibility of total artificial heart (TAH) implantation in humans. The Utah TAH
consists of two spherical ventricles fabricated of polyurethane which are
pneumatically powered by an external driver. The TAH use tilting-disk valves.
A 61-year-old man presented with end-stage heart failure due to idiopathic
cardiomyopathy which was refractory to drug therapy With informed consent,
the TAH was successfully implanted and allowed survival for 112 days. After
implantation, increases occurred in blood pressure, from 85/70 to 124/60 mm
Hg, left ventricular ejection fraction, from 10% to 77%, and cardiac output,
from 1.5 to 71/min. The patient awakened after three hours and was fully alert.
He later could be ambulated and exercised with assistance. The postoperative
period was complicated by pulmonary insufficiency, intermittent renal failure,
seizures (? overperfusion), bleeding complications of anticoagulation, and
pseudomembranous colitis with terminal shock Except for an early valve
failure which was corrected, the TAH was functional throughout the clinical
course and was intact at autopsy This initial experience indicates the feasibility
of long-term cardiovascular support with a TAH systems, and suggests promise
for further development.

At the conclusion of his keynote address, Dr. DeVries described the experience
as "inspiring" for all who participated. Other such artificial heart transplants
have occurred subsequently and will undoubtedly continue to occur at an
accelerated rate as technology improves.
Summary and Conclusions
:Francois Magendie, a French physiologist of the early nineteenth century,
and considered by many to be the father of experimental physiology, was
succeeded at the College of France by his former assistant, Claude Bernard.
Bernard was a brilliant physiologist who was described by Pasteur as physiology itself. Every phase of physiology to which Bernard addressed himself
was explored with innumerable experiments. Bernard did not lack sensitivity
towards the animals he used, nor to the views of his anti-vivisectionist
opponents. Yet he was undaunted in his belief that his work was justified
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by the potential benefits derived for humanity. In his book, An Introduction
to the Study ofExperimental Medicine (Bernard 1957), he asks the question:
Have we the right to make experiments on animals and vivisect d1em? ... I think
we have this right, wholly and absolutely. It would be strange indeed if we
recognized man's right to make use of animals in every walk of life, for domestic
service, for food, and then forbade him to make use of them for his own
instruction in one of the sciences most useful to humanity. No hesitation is
possible; the science of life can be established only through experiment, and
we can save living beings from death only after sacrificing others. Experiments
must be made either on man or on animals. Now I think that physicians already
make too many dangerous experiments on man, before carefully studying them
on animals. I do not admit that it is moral to try more or less dangerous or
active remedies on patients in hospitals, without first experimenting with them
on dogs; for I shall prove, further on, that results obtained on animals may all
be conclusive for man when we know how to experiment properly.

The author reaffirms the beliefs held by Claude Bernard. If our motivation
for using animals in experimental investigation is to improve the welfare of
humanity (and other forms of animal life), then by all means it is not only
our right but perhaps our obligation to continue such work
At a time when the use of animals in experimental research is being
seriously debated, it is important to step back and review what has been
learned and what may lay ahead in the field of biomedical research and
medicine. Scientists as well as the lay public are bound by ethical and moral
principles to treat living creatures with respect and to protect their environment. By the manner in which we address relevant biological questions, so
shall we be judged by our peers and the public. By the manner in which
we manage our environment, so will we be judged by future generations.
In the final analysis, it is the function of society to determine whether the
gain from animal research with its attendant benefit to man and the environment is justified Qonas 1984).
The use of animals in experimental research is by its very nature an
encroachment on those precepts respecting animal life Qonas 1984). Nonetheless, man is given by divine decree, " ... dominion over the fish of the sea,
and over the fowl of the air, and over every living thing that moveth upon
the earth" (Genesis 1:28). Therefore, it is incumbent not only on scientists
who use animals in medical research, but on every person who uses animals
for any purpose to do so with care, compassion, and consideration for the
animal's well-being.
Endnotes
1 Paper presented at the national conference, "Animals and Humans: Ethical Perspectives,"
Moorhead State University, Moorhead, MN, April 21-23, 1986.
2 Associate Professor, Graduate Program in Physiology, Bartlett Hall, Cook College, Rutgers
University, New Brunswick, NJ 08903.
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